Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma (NAMS) Treasury Shares (2022 - 2025)

NewAmsterdam Pharma's Treasury Shares history spans 4 years, with the latest figure at $728283.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 409.28% year-over-year to $728283.0; the TTM value through Dec 2025 reached $728283.0, up 409.28%, while the annual FY2025 figure was $728283.0, 409.28% up from the prior year.
  • Treasury Shares for Q4 2025 was $728283.0 at NewAmsterdam Pharma, roughly flat from $724908.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $728283.0 in Q4 2025 and bottomed at $143002.0 in Q4 2024.
  • The 4-year median for Treasury Shares is $614942.1 (2022), against an average of $603478.8.
  • The largest annual shift saw Treasury Shares crashed 76.51% in 2024 before it skyrocketed 409.28% in 2025.
  • A 4-year view of Treasury Shares shows it stood at $621105.2 in 2022, then decreased by 1.98% to $608779.0 in 2023, then plummeted by 76.51% to $143002.0 in 2024, then surged by 409.28% to $728283.0 in 2025.
  • Per Business Quant, the three most recent readings for NAMS's Treasury Shares are $728283.0 (Q4 2025), $724908.0 (Q3 2025), and $718584.0 (Q2 2025).